Market Tracker

04/17 6:05pm ET

Sunesis Pharmaceuticals Inc (NASDAQ:SNSS)

5.16
Data as of Apr 17
 -0.02 / -0.39%
Today’s Change
3.84
Today|||52-Week Range
7.49
+8.86%
Year-to-Date

Today’s Trading

Previous close5.18
Today’s open5.14
Day’s range5.08 - 5.32
Volume294,269
Average volume (3 months)859,039
Market cap$351.0M
Dividend yield--
Data as of 3:59pm ET, 04/17/2014

Growth & Valuation

Earnings growth (last year)+27.47%
Earnings growth (this year)+5.63%
Earnings growth (next 5 years)--
Revenue growth (last year)+111.93%
P/E ratioNM
Price/Sales31.13
Price/Book--

Competitors

 Today’s
change
Today’s
% change
FLMLFlamel Technologies ...+0.66+6.23%
RPRXRepros Therapeutics ...+0.28+1.78%
DRNADicerna Pharmaceutic...+0.11+0.67%
SNTASynta Pharmaceutical...-0.07-1.73%
Data as of 3:59pm ET, 04/17/2014

Financials

Next reporting dateMay 7, 2014
EPS forecast (this quarter)-$0.17
Annual revenue (last year)$8.0M
Annual profit (last year)-$34.6M
Net profit margin-434.87%

Profile

Sector
Health Technology
Industry
Biotechnology
President &
Chief Executive Officer
Daniel N. Swisher
CFO, Secretary &
EVP-Corporate Development
Eric H. Bjerkholt
Corporate headquarters
South San Francisco, California

Forecasts